Journal articleJ Addict Med · May 2026
OBJECTIVES: Injection drug use is a leading and growing risk factor for infective endocarditis (IE), as evidenced by a marked national increase in hospitalizations for drug use-associated infective endocarditis (DUA-IE). The typical treatment approach for ...
Full textOpen AccessLink to itemCite
Journal articleSubst Use Addctn J · January 2026
BACKGROUND: Infective endocarditis (IE) rates have risen sharply, spurred by injection drug use (IDU). Public health interventions to prevent infectious complications of IDU have primarily focused on communicable diseases, such as HIV and viral hepatitis. ...
Full textOpen AccessLink to itemCite
Journal articleTher Adv Infect Dis · 2025
BACKGROUND: Infective endocarditis (IE) has increased markedly among people who inject drugs (PWID). Harm reduction is a tool to help PWID improve health outcomes and mitigate IE. OBJECTIVES: To understand the knowledge, perceptions, past engagement, and p ...
Full textOpen AccessLink to itemCite
Journal articleInfect Dis Clin North Am · December 2024
Infections associated with cardiac implantable electronic devices (CIEDs) are increasing and are a cause of significant morbidity and mortality. This article summarizes the latest updates with respect to the epidemiology, microbiology, and risk factors for ...
Full textLink to itemCite
Journal articleClin Infect Dis · July 19, 2024
Among a statewide cohort of 1874 patients surviving hospitalization for drug use-associated endocarditis during 2017-2020, the 3-year risk of death or future hospitalization was 38% (16% for death before later infection, 14% for recurrent endocarditis, 14% ...
Full textOpen AccessLink to itemCite
Journal articleJACC Cardiovasc Imaging · June 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal articleHeart Rhythm · May 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal articleJ Nucl Cardiol · April 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal articleClin Infect Dis · March 11, 2024
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the eva ...
Full textLink to itemCite
Journal articleClin Infect Dis · January 25, 2024
BACKGROUND: Scarce data are available comparing infective endocarditis (IE) following surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). This study aimed to compare the clinical presentation, microbiological profile ...
Full textLink to itemCite
Journal articleCirculation · January 9, 2024
The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infect ...
Full textLink to itemCite
Journal articleInfectious Diseases and Therapy · December 1, 2023
In the original publication of the article, there was an error with the map presented in Fig. 1 and the Graphical Abstract. The correct version of Fig. 1 and the Graphical Abstract are given below. The original article has also been updated. (Figure presen ...
Full textCite
Journal articleOral Surg Oral Med Oral Pathol Oral Radiol · September 2023
OBJECTIVE: To determine if oral hygiene is associated with infective endocarditis (IE) among those at moderate risk for IE. STUDY DESIGN: This is a case control study of oral hygiene among hospitalized patients with IE (cases) and outpatients with heart va ...
Full textLink to itemCite
Journal articleJ Gen Intern Med · May 2023
BACKGROUND: Hospitalizations for infective endocarditis (IE) associated with opioid use disorder (O-IE) have increased in the USA and have been linked to high rates of discharge against medical advice (DAMA). DAMA represents a truncation of care for a seve ...
Full textOpen AccessLink to itemCite
Journal articleInfectious Diseases and Therapy · April 1, 2023
Introduction: Infective endocarditis (IE) has undergone important changes in its epidemiology worldwide. Methods: The study aimed to compare IE epidemiological features and outcomes according to predefined European regions and between two different time pe ...
Full textCite
Journal articleJ Infect · August 2022
OBJECTIVE: To describe the clinical characteristics and outcome of Abiotrophia and Granulicatella infective endocarditis and compare them with Viridans group streptococci infective endocarditis. METHODS: All patients in the International Collaboration on E ...
Full textLink to itemCite
Journal articleJADA Found Sci · 2022
BACKGROUND: Infective endocarditis (IE) is an uncommon disease, but it is associated with high morbidity and mortality. The low incidence and varied clinical presentation make identification of these patients recently admitted to hospitals particularly cha ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · April 6, 2021
BACKGROUND: Infective endocarditis (IE) is a common and serious complication in patients receiving chronic hemodialysis (HD). OBJECTIVES: This study sought to investigate whether there are significant differences in complications, cardiac surgery, relapses ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · February 9, 2021
BACKGROUND: Infective endocarditis (IE) in people who inject drugs (PWID) is an emergent public health problem. OBJECTIVES: The purpose of this study was to investigate IE in PWID and compare it with IE in non-PWID patients. METHODS: Two prospective cohort ...
Full textLink to itemCite
Journal articleOpen Forum Infect Dis · May 2020
BACKGROUND: Beta-hemolytic streptococci (BHS) are an uncommon cause of infective endocarditis (IE). The aim of this study was to describe the clinical features and outcomes of patients with BHS IE in a large multinational cohort and compare them with patie ...
Full textLink to itemCite
Journal articleJ Hosp Infect · February 2020
Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating ...
Full textLink to itemCite
Journal articleJ Neonatal Perinatal Med · 2020
BACKGROUND: Given the limited available evidence on chloral hydrate safety in neonatal populations and the discrepancy in chloral hydrate acceptance between the US and other countries, we sought to clarify the safety profile of chloral hydrate compared to ...
Full textLink to itemCite
Journal articleJ Heart Lung Transplant · April 2019
BACKGROUND: Despite advances in device technology and treatment strategies, infection remains a major cause of adverse events (AEs) in mechanical circulatory support (MCS) patients. To characterize the epidemiology of MCS infection, we examined the type, l ...
Full textLink to itemCite
Journal articleAm Heart J · April 2019
BACKGROUND: In patients with active infective endocarditis (IE), the relationship between timing of surgery and survival is uncertain. The objective was to evaluate clinical characteristics associated with timing of surgery and the association between surg ...
Full textLink to itemCite
Journal articleAnn Intern Med · January 1, 2019
BACKGROUND: Drug use-associated infective endocarditis (DUA-IE) is increasing as a result of the opioid epidemic. Infective endocarditis may require valve surgery, but surgical treatment of DUA-IE has invoked controversy, and the extent of its use is unkno ...
Full textOpen AccessLink to itemCite
Journal articleInfect Dis Clin North Am · December 2018
Infections associated with cardiac implantable electronic devices are increasing and are associated with significant morbidity and mortality. This article reviews the epidemiology, microbiology, and risk factors for acquisition of these infections. The com ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · November 13, 2018
BACKGROUND: The American Heart Association updated its recommendations for antibiotic prophylaxis (AP) to prevent infective endocarditis (IE) in 2007, advising that AP cease for those at moderate risk of IE, but continue for those at high risk. OBJECTIVES: ...
Full textLink to itemCite
Journal articleJAMA · September 25, 2018
IMPORTANCE: The appropriate duration of antibiotics for staphylococcal bacteremia is unknown. OBJECTIVE: To test whether an algorithm that defines treatment duration for staphylococcal bacteremia vs standard of care provides noninferior efficacy without in ...
Full textOpen AccessLink to itemCite
Journal articleJ Heart Lung Transplant · August 2018
BACKGROUND: We used multicenter international data from the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support (IMACS) registry to determine bloodstream infection (BSI) event rate, independent risk factors, an ...
Full textLink to itemCite
Journal articleJAMA · July 3, 2018
IMPORTANCE: Infective endocarditis occurs in approximately 15 of 100 000 people in the United States and has increased in incidence. Clinicians must make treatment decisions with respect to prophylaxis, surgical management, specific antibiotics, and the le ...
Full textLink to itemCite
Journal articleClin Microbiol Infect · August 2017
OBJECTIVES: Left-sided methicillin-susceptible Staphylococcus aureus (MSSA) endocarditis treated with cloxacillin has a poorer prognosis when the vancomycin minimum inhibitory concentration (MIC) is ≥1.5 mg/L. We aimed to validate this using the Internatio ...
Full textOpen AccessLink to itemCite
Journal articleAntimicrob Agents Chemother · October 2016
The phenotypic expression of methicillin resistance among coagulase-negative staphylococci (CoNS) is heterogeneous regardless of the presence of the mecA gene. The potential discordance between phenotypic and genotypic results has led to the use of vancomy ...
Full textOpen AccessLink to itemCite
Journal articleEarly Hum Dev · August 2016
BACKGROUND: Histamine-2 receptor (H2) blockers are often used in very low birth weight infants despite lack of population specific efficacy and safety data. AIMS: We sought to describe safety and temporal trends in histamine-2 receptor (H2) blocker use in ...
Full textLink to itemCite
Journal articleJ Antimicrob Chemother · July 2016
OBJECTIVES: Although controversy exists regarding the efficacy of antibiotic prophylaxis for patients at risk of infective endocarditis, expert committees continue to publish recommendations for antibiotic prophylaxis regimens. This study aimed to evaluate ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · April 18, 2016
BACKGROUND: Host factors and complications have been associated with higher mortality in infective endocarditis (IE). We sought to develop and validate a model of clinical characteristics to predict 6-month mortality in IE. METHODS AND RESULTS: Using a lar ...
Full textLink to itemCite
Journal articleJ Pediatr · March 2016
OBJECTIVE: To assess the effect of enteral feeding with human milk on the time from initiation of feeds to discharge after gastroschisis repair through review of a multi-institutional database. STUDY DESIGN: Infants who underwent gastroschisis repair betwe ...
Full textLink to itemCite
Journal articleAnn Am Thorac Soc · March 2016
RATIONALE: Limitations in methods for the rapid diagnosis of hospital-acquired infections often delay initiation of effective antimicrobial therapy. New diagnostic approaches offer potential clinical and cost-related improvements in the management of these ...
Full textOpen AccessLink to itemCite
Journal articleJ Infect · March 2016
BACKGROUND: Phenol-soluble modulins (PSM) are amphipathic proteins produced by Staphylococcus aureus that promote virulence, inflammatory response, and biofilm formation. We previously showed that MRSA isolates from soft tissue infection (SSTI) produced si ...
Full textLink to itemCite
Journal articleJ Pediatr Gastroenterol Nutr · September 2015
OBJECTIVE: Prokinetic medications are used in premature infants to promote motility and decrease time to full enteral feeding. Erythromycin and metoclopramide are the most commonly used prokinetic medications in the neonatal intensive care unit (NICU), but ...
Full textLink to itemCite
Journal articlePediatr Infect Dis J · September 2015
BACKGROUND: Cefepime and ceftazidime are cephalosporins used for the treatment of serious Gram-negative infections. These cephalosporins are used off-label in the setting of minimal safety data for young infants. METHODS: We identified all infants discharg ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Imaging · July 2015
BACKGROUND: Staphylococcus aureus left-sided native valve infective endocarditis (LNVIE) has higher complication and mortality rates compared with endocarditis from other pathogens. Whether echocardiographic variables can predict prognosis in S aureus LNVI ...
Full textLink to itemCite
Journal articleAm J Perinatol · May 2015
OBJECTIVE: This study aims to examine the use and safety of rifampin in the hospitalized infants. STUDY DESIGN: Observational study of clinical and laboratory adverse events among infants exposed to rifampin from 348 neonatal intensive care units managed b ...
Full textLink to itemCite
Journal articleAntimicrob Agents Chemother · April 2015
Candida infective endocarditis is a rare disease with a high mortality rate. Our understanding of this infection is derived from case series, case reports, and small prospective cohorts. The purpose of this study was to evaluate the clinical features and u ...
Full textLink to itemCite
Journal articleClin Infect Dis · March 1, 2015
BACKGROUND: The impact of early valve surgery (EVS) on the outcome of Staphylococcus aureus (SA) prosthetic valve infective endocarditis (PVIE) is unresolved. The objective of this study was to evaluate the association between EVS, performed within the fir ...
Full textLink to itemCite
Journal articleInt J Cardiol · January 15, 2015
BACKGROUND: Nearly half of patients require cardiac surgery during the acute phase of infective endocarditis (IE). We describe the characteristics of patients according to the type of valve replacement (mechanical or biological), and examine whether the ty ...
Full textLink to itemCite
Journal articleCirculation · January 13, 2015
BACKGROUND: Use of surgery for the treatment of infective endocarditis (IE) as related to surgical indications and operative risk for mortality has not been well defined. METHODS AND RESULTS: The International Collaboration on Endocarditis-PLUS (ICE-PLUS) ...
Full textLink to itemCite
Journal articleClin Microbiol Infect · June 2014
Repeat episodes of infective endocarditis (IE) can occur in patients who survive an initial episode. We analysed risk factors and 1-year mortality of patients with repeat IE. We considered 1874 patients enrolled in the International Collaboration on Endoca ...
Full textLink to itemCite
Journal articleGlob Heart · March 2014
Infective endocarditis (IE) is a life-threatening disease associated with serious complications. The GBD 2010 (Global Burden of Disease, Injuries, and Risk Factors) study IE expert group conducted a systematic review of IE epidemiology literature to inform ...
Full textLink to itemCite
Journal articleAntimicrob Agents Chemother · December 2013
The use of daptomycin in Gram-positive left-sided infective endocarditis (IE) has significantly increased. The purpose of this study was to assess the influence of high-dose daptomycin on the outcome of left-sided IE due to Gram-positive pathogens. This wa ...
Full textOpen AccessLink to itemCite
Journal articleClin Microbiol Infect · December 2013
Enterococci are reportedly the third most common group of endocarditis-causing pathogens but data on enterococcal infective endocarditis (IE) are limited. The aim of this study was to analyse the characteristics and prognostic factors of enterococcal IE wi ...
Full textLink to itemCite
Journal articleJAMA Intern Med · September 9, 2013
IMPORTANCE: There are limited prospective, controlled data evaluating survival in patients receiving early surgery vs medical therapy for prosthetic valve endocarditis (PVE). OBJECTIVE: To determine the in-hospital and 1-year mortality in patients with PVE ...
Full textLink to itemCite
Journal articleClin Infect Dis · January 2013
BACKGROUND: The timing of cardiac surgery after stroke in infective endocarditis (IE) remains controversial. We examined the relationship between the timing of surgery after stroke and the incidence of in-hospital and 1-year mortalities. METHODS: Data were ...
Full textLink to itemCite
Journal articlePLoS One · 2013
The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) are rare causes of infective endocarditis (IE). The objective of this study is to describe the clinical characteristics a ...
Full textLink to itemCite
Journal articleJAMA · April 25, 2012
CONTEXT: Infection of implantable cardiac devices is an emerging disease with significant morbidity, mortality, and health care costs. OBJECTIVES: To describe the clinical characteristics and outcome of cardiac device infective endocarditis (CDIE) with att ...
Full textLink to itemCite
Journal articleJAMA · November 23, 2011
CONTEXT: Heart failure (HF) is the most common complication of infective endocarditis. However, clinical characteristics of HF in patients with infective endocarditis, use of surgical therapy, and their associations with patient outcome are not well descri ...
Full textLink to itemCite
Journal articleBMC Res Notes · November 2, 2011
BACKGROUND: Ertapenem is a once-daily broad spectrum carbapenem that is increasingly used to treat polymicrobial osteomyelitis due to diabetic foot and traumatic wound infections. However, limited data exists on ertapenem use for osteomyelitis. This study ...
Full textLink to itemCite
Journal articleJ Infect Dis · September 1, 2011
BACKGROUND: Using multinational collections of methicillin-susceptible Staphylococcus aureus (MSSA) isolates from infective endocarditis (IE) and soft tissue infections (STIs), we sought to (1) validate the finding that S. aureus in clonal complex (CC) 30 ...
Full textLink to itemCite
Journal articleBMJ · May 3, 2011
OBJECTIVE: To quantify the change in prescribing of antibiotic prophylaxis before invasive dental procedures for patients at risk of infective endocarditis, and any concurrent change in the incidence of infective endocarditis, following introduction of a c ...
Full textLink to itemCite
Journal articleCirculation · March 2, 2010
BACKGROUND: The impact of early surgery on mortality in patients with native valve endocarditis (NVE) is unresolved. This study sought to evaluate valve surgery compared with medical therapy for NVE and to identify characteristics of patients who are most ...
Full textOpen AccessLink to itemCite
Journal articleJ Infect · May 2009
OBJECTIVES: To assess the influence of acetyl-salicylic acid (ASA) on clinical outcomes in Staphylococcus aureus infective endocarditis (SA-IE). METHODS: The International Collaboration on Endocarditis - Prospective Cohort Study database was used in this o ...
Full textLink to itemCite
Journal articleHeart · April 2009
OBJECTIVE: To describe the contemporary features of coagulase-negative staphylococcal (CoNS) prosthetic valve endocarditis (PVE). DESIGN: Observational study of prospectively collected data from a multinational cohort of patients with infective endocarditi ...
Full textLink to itemCite
Journal articleHeart · April 2009
BACKGROUND: Previous studies have suggested that living in a multi-generational household (a type of family structure prevalent in Japan) confers mixed health benefits and stresses, especially for women who report such living arrangements. OBJECTIVE: To ex ...
Full textLink to itemCite
Journal articleArch Intern Med · March 9, 2009
BACKGROUND: We sought to provide a contemporary picture of the presentation, etiology, and outcome of infective endocarditis (IE) in a large patient cohort from multiple locations worldwide. METHODS: Prospective cohort study of 2781 adults with definite IE ...
Full textLink to itemCite
Journal articleAm J Med · March 2009
BACKGROUND: Although Staphylococcus aureus bacteremia is a common, serious infection, accurately identifying febrile patients with this diagnosis at the time of initial evaluation is difficult. The purpose of this investigation was to define clinical chara ...
Full textLink to itemCite
Journal articleInfect Immun · November 2008
Staphylococcus epidermidis is one of the most common causes of infections of prosthetic heart valves (prosthetic valve endocarditis [PVE]) and an increasingly common cause of infections of native heart valves (native valve endocarditis [NVE]). While S. epi ...
Full textLink to itemCite
Journal articleJ Clin Microbiol · September 2008
We investigated associations between the genotypic and phenotypic features of Staphylococcus aureus bloodstream isolates and the clinical characteristics of bacteremic patients enrolled in a phase III trial of S. aureus bacteremia and endocarditis. Isolate ...
Full textLink to itemCite
Journal articleEur J Clin Microbiol Infect Dis · July 2008
Candida infective endocarditis (IE) is uncommon but often fatal. Most epidemiologic data are derived from small case series or case reports. This study was conducted to explore the epidemiology, treatment patterns, and outcomes of patients with Candida IE. ...
Full textLink to itemCite
Journal articleJ Clin Microbiol · May 2008
Coagulase-negative staphylococci (CNS) are important causes of infective endocarditis (IE), but their microbiological profiles are poorly described. We performed DNA target sequencing and susceptibility testing for 91 patients with definite CNS IE who were ...
Full textLink to itemCite
Journal articleHeart · May 2008
BACKGROUND: Despite widespread acceptance of echocardiography for diagnosis of infective endocarditis, few investigators have evaluated its utility as a risk-stratification tool to aid therapeutic decision-making. METHODS: A decision tree and Markov analys ...
Full textLink to itemCite
Journal articleClin Infect Dis · January 15, 2008
BACKGROUND: Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding of NVE caused by CoNS is incomplete. METHOD: The International Collaboration on Endocarditis-Prospective Cohort Study incl ...
Full textLink to itemCite
Journal articleScand J Infect Dis · 2008
We evaluated costs and outcomes of patients with S. aureus bacteremia and orthopedic device infections (ODI). Patients with ODI had higher relapse of S. aureus infection, compared to bacteremic patients without ODI. Costs and outcomes were similar among OD ...
Full textLink to itemCite
Journal articleAnn Intern Med · December 18, 2007
BACKGROUND: Infective endocarditis caused by non-HACEK (species other than Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, or Kingella species) gram-negative bacilli is rare, is poorly characterized, ...
Full textLink to itemCite
Journal articleJ Infect Dis · November 1, 2007
BACKGROUND: Endogenous antimicrobial peptides participate in the innate defense of skin against a variety of pathogens. The systemic expression of these peptides in normal-appearing skin of patients with infective cellulitis is unknown. METHODS: Study pati ...
Full textLink to itemCite
Journal articleCurr Infect Dis Rep · July 2007
The first use of echocardiography in infective endocarditis (IE) was described in 1973. Since then, echocardiography has emerged as a major tool for the diagnosis and management of this disease. In general, transthoracic echocardiography (TTE) is adequate ...
Full textLink to itemCite
Journal articleClin Infect Dis · February 1, 2007
BACKGROUND: An accurate assessment of the predictors of long-term mortality in patients with infective endocarditis is not possible using retrospective data because of inherent treatment biases and predictable imbalances in the distribution of prognostic f ...
Full textLink to itemCite
Journal articleClin Infect Dis · January 15, 2007
BACKGROUND: Because of its ease of dosing, vancomycin is commonly used to treat methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia in patients undergoing long-term hemodialysis. Clinical outcomes resulting from such a therapeutic strategy have ...
Full textLink to itemCite
Journal articleEur J Clin Microbiol Infect Dis · June 2006
Infective endocarditis due to coagulase-negative staphylococci is increasingly recognized as a difficult-to-treat disease associated with poor outcome. The aim of this report is to describe the characteristics and outcome of patients with prosthetic valve ...
Full textLink to itemCite
Journal articleAntimicrob Agents Chemother · March 2006
Telavancin is a bactericidal lipoglycopeptide with a multifunctional mechanism of action. We conducted a randomized, double blind, active-control phase II trial. Patients > or = 18 years of age with complicated skin and skin structure infections caused by ...
Full textLink to itemCite
Journal articleAm J Med · December 2005
PURPOSE: Although Staphylococcus aureus is a leading cause of nosocomial infection, little is known about the impact of S. aureus bacteremia on patients with prosthetic devices. This investigation sought to define the clinical outcome, health care resource ...
Full textLink to itemCite
Journal articleClin Infect Dis · August 1, 2005
Repeat infective endocarditis due to the same species can represent relapse of the initial infection or a new infection. We used time-based clinical criteria and pulsed-field gel electrophoresis-based molecular criteria to classify 13 cases of repeat infec ...
Full textLink to itemCite
Journal articleClin Infect Dis · June 1, 2005
BACKGROUND: Telavancin, a novel lipoglycopeptide, exerts concentration-dependent, rapid bactericidal activity on account of its multiple mechanisms of action. Telavancin is highly active against gram-positive bacteria, including methicillin-resistant Staph ...
Full textLink to itemCite
Journal articleAm J Med · March 2005
PURPOSE: Staphylococcus aureus is a common cause of bacteremia and of native valve infective endocarditis. However, the risk of endocarditis in patients with a prosthetic valve who develop S. aureus bacteremia is unclear. The aim of this study was to defin ...
Full textLink to itemCite
Journal articleClin Infect Dis · November 15, 2004
Using a large cohort of patients from the International Collaboration on Endocarditis Merged Database, we compared coagulase-negative staphylococcal (CoNS) native-valve endocarditis (NVE) to NVE caused by more common pathogens. Rates of heart failure and m ...
Full textLink to itemCite
Journal articleCurr Infect Dis Rep · August 2004
Most cases of infective endocarditis (IE) are caused by gram-positive bacteria such as enterococci, streptococci, and staphylococci. Increasing resistance among these organisms has eroded the utility of mainstay antibiotics and complicated the management o ...
Full textLink to itemCite
Journal articleCirculation · April 13, 2004
BACKGROUND: Data on early determinants of outcome in infective endocarditis (IE) are limited. We evaluated the prognostic significance of early clinical characteristics in a large, prospective cohort of patients with IE. METHODS AND RESULTS: Two hundred si ...
Full textLink to itemCite
Journal articleAm Heart J · April 2004
BACKGROUND: Although cardiac devices have been found to reduce symptoms and mortality rates in appropriate patient populations, the implications of certain important risks, such as infection, are incompletely understood. The purpose of this study was to us ...
Full textLink to itemCite